Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2343]
News [4865]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
Hypoxic metabolism in breast cancer: how to overcome resistance to anti...
Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013
Where to next for the elderly with acute myeloid leukaemia?
Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert...
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013
Long term use of aromatase inhibitors and compliance
Prof Peter Barrett-Lee - Cardiff University, UK
Long term use of aromatase inhibitors and compliance ( Prof Peter Barrett-Lee - Cardiff University, UK )
18 Dec 2013
New line of therapy for acute myeloid leukaemia
Dr David Taussig - Barts Cancer Institute, London, UK
New line of therapy for acute myeloid leukaemia ( Dr David Taussig - Barts Cancer Institute, London, UK )
18 Dec 2013
Novel agent CC-292 for CLL using the B-cell receptor pathway
Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
Novel agent CC-292 for CLL using the B-cell receptor pathway ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013
Encouraging early results with GS-9973 for CLL and NHL
Dr Jeff Sharman- US Oncology, Eugene, Oregon
Encouraging early results with GS-9973 for CLL and NHL ( Dr Jeff Sharman- US Oncology, Eugene, Oregon )
18 Dec 2013
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for...
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille...
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...
Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers...
Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )
16 Dec 2013
Avoiding radiotherapy is an option for some older patients with breast cancer
Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK
Avoiding radiotherapy is an option for some older patients with breast cancer ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )
16 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation